Frontline : Polyfunctional T cell responses are a hallmark of HIV-2 infection

HIV‐2 is distinguished clinically and immunologically from HIV‐1 infection by delayed disease progression and maintenance of HIV‐specific CD4+ T cell help in most infected subjects. Thus, HIV‐2 provides a unique natural human model in which to investigate correlates of immune protection against HIV disease progression. Here, we report a detailed assessment of the HIV‐2‐specific CD4+ and CD8+ T cell response compared to HIV‐1, using polychromatic flow cytometry to assess the quality of the HIV‐specific T cell response by measuring IFN‐γ, IL‐2, TNF‐α, MIP‐1β, and CD107a mobilization (degranulation) simultaneously following Gag peptide stimulation. We find that HIV‐2‐specific CD4+ and CD8+ T cells are more polyfunctional that those specific for HIV‐1 and that polyfunctional HIV‐2‐specific T cells produce more IFN‐γ and TNF‐α on a per‐cell basis than monofunctional T cells. Polyfunctional HIV‐2‐specific CD4+ T cells were generally more differentiated and expressed CD57, while there was no association between function and phenotype in the CD8+ T cell fraction. Polyfunctional HIV‐specific T cell responses are a hallmark of non‐progressive HIV‐2 infection and may be related to good clinical outcome in this setting.

[1]  F. Gao,et al.  Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. McElrath,et al.  Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. , 1999, The Journal of infectious diseases.

[3]  M. Melbye,et al.  9-year HIV-2-associated mortality in an urban community in Bissau, west Africa , 1997, The Lancet.

[4]  Annapurna Vyakarnam,et al.  Presence of HIV-1 Gag-Specific IFN-γ+IL-2+ and CD28+IL-2+ CD4 T Cell Responses Is Associated with Nonprogression in HIV-1 Infection1 , 2002, The Journal of Immunology.

[5]  A. Hill,et al.  Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope. , 1993, Journal of immunology.

[6]  Mario Roederer,et al.  Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses , 2007, The Journal of experimental medicine.

[7]  H. Whittle,et al.  Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. , 1998, Journal of human virology.

[8]  Steve Kaye,et al.  Cytomegalovirus Infection in Gambian Infants Leads to Profound CD8 T-Cell Differentiation , 2007, Journal of Virology.

[9]  Laurie Lamoreaux,et al.  Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. , 2006, Journal of immunological methods.

[10]  L. Pinto,et al.  T‐helper reactivity to simian immunodeficiency virus gag synthetic peptides in human immunodeficiency virus type 2 infected individuals , 1995, Journal of medical virology.

[11]  Z. Grossman,et al.  HIV preferentially infects HIV-specific CD4+ T cells , 2002, Nature.

[12]  M. Clerici,et al.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. , 1989, The Journal of clinical investigation.

[13]  Mario Roederer,et al.  Ex vivo identification, isolation and analysis of tumor-cytolytic T cells , 2003, Nature Medicine.

[14]  B. Thiers,et al.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2008 .

[15]  B. Walker,et al.  Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. , 2007, Immunity.

[16]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[17]  H. Whittle,et al.  Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers. , 2002, AIDS research and human retroviruses.

[18]  G. Pantaleo,et al.  Functional Heterogeneity of Memory CD4 T Cell Responses in Different Conditions of Antigen Exposure and Persistence1 , 2005, The Journal of Immunology.

[19]  Jeffrey N. Martin,et al.  Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment , 2005, Journal of Virology.

[20]  R. Koup,et al.  Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations , 2007, European journal of immunology.

[21]  L. Borysiewicz,et al.  Subsets of CD8 +, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses , 1993, Clinical and experimental immunology.

[22]  S. Popper,et al.  Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections. , 1999, Journal of Human Virology.

[23]  Mario Roederer,et al.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2007, Nature Medicine.

[24]  R. Koup,et al.  Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation , 2006, The Journal of experimental medicine.

[25]  H. Whittle,et al.  A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa. , 1996, The Journal of infectious diseases.

[26]  J. Falloon,et al.  Vaccination in Humans Generates Broad T Cell Cytokine Responses1 , 2004, The Journal of Immunology.

[27]  G. Pantaleo,et al.  HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Whittle,et al.  HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals. , 1994, AIDS research and human retroviruses.

[29]  A. E. Sousa,et al.  Comparison of the frequency of interleukin (IL)-2-, interferon-gamma-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes. , 2001, The Journal of infectious diseases.

[30]  Anthony D. Kelleher,et al.  Characterization of CD4+ CTLs Ex Vivo1 , 2002, The Journal of Immunology.

[31]  P. Henkart Mechanism of lymphocyte-mediated cytotoxicity. , 1985, Annual review of immunology.

[32]  H. Whittle,et al.  Cytotoxic T Cells from Human Immunodeficiency Virus Type 2-Infected Patients Frequently Cross-React with Different Human Immunodeficiency Virus Type 1 Clades , 1998, Journal of Virology.

[33]  S. Rowland-Jones,et al.  Maintenance of HIV-Specific CD4+ T Cell Help Distinguishes HIV-2 from HIV-1 Infection1 , 2006, The Journal of Immunology.

[34]  R. Koup,et al.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. , 2003, Journal of immunological methods.

[35]  S. Rowland-Jones,et al.  CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV‐2) and type 1 (HIV‐1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype , 2005, European journal of immunology.

[36]  S. Rowland-Jones,et al.  HIV-2 and T cell recognition. , 1998, Current opinion in immunology.

[37]  P. Lehner,et al.  CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. , 1995, Journal of immunology.

[38]  G. Pantaleo,et al.  Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. , 2004, Blood.

[39]  Z. Grossman,et al.  HIV-1 Viremia Prevents the Establishment of Interleukin 2–producing HIV-specific Memory CD4+ T Cells Endowed with Proliferative Capacity , 2003, The Journal of experimental medicine.

[40]  Mario Roederer,et al.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.

[41]  H. Whittle,et al.  Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia , 2002, AIDS.

[42]  J. Albert,et al.  Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from guinea-bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa. , 1999, Virology.

[43]  J. Bluestone,et al.  The role of cytoplasmic granules in cytotoxicity by large granular lymphocytes and cytotoxic T lymphocytes. , 1985, Advances in experimental medicine and biology.

[44]  H. Whittle,et al.  No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients. , 2004, The Journal of infectious diseases.

[45]  C. Pitcher,et al.  HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression , 1999, Nature Medicine.

[46]  Study of HIV type 1 gag/env variability in The Gambia, using a multiplex DNA polymerase chain reaction. , 2000, AIDS research and human retroviruses.

[47]  G. Gottlieb,et al.  Comparison of Human Immunodeficiency Virus (HIV)-Specific T-Cell Responses in HIV-1- and HIV-2-Infected Individuals in Senegal , 2004, Journal of Virology.

[48]  D. Price,et al.  Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry , 2006, Nature Medicine.

[49]  H. Whittle,et al.  Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa , 2000, AIDS.

[50]  Anthony D Kelleher,et al.  Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection. , 2004, Blood.

[51]  Alison Johnson,et al.  Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+ T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 , 2003, Journal of Virology.